Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Wilby, J., Kainth, A, Hawkins, N, Epstein, D, McIntosh, H, McDaid, C, Mason, A, Golder, S, O'Meara, S, Sculpher, M, & others Health Technology Assessment, 2005. bibtex @article{wilby_clinical_2005-1,
title = {Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation},
journal = {Health Technology Assessment},
author = {Wilby, Jennifer and Kainth, A and Hawkins, N and Epstein, D and McIntosh, H and McDaid, C and Mason, A and Golder, S and O'Meara, S and Sculpher, M and {others}},
year = {2005},
keywords = {Adolescent, Adult, Anticonvulsants, Clinical Trials as Topic, Cost-Benefit Analysis, Epilepsy, Female, Humans, Male, Randomized Controlled Trials as Topic, Treatment Outcome, United Kingdom},
}
Downloads: 0
{"_id":"jyygG396GPheH2bPY","bibbaseid":"wilby-kainth-hawkins-epstein-mcintosh-mcdaid-mason-golder-etal-clinicaleffectivenesstolerabilityandcosteffectivenessofnewerdrugsforepilepsyinadultsasystematicreviewandeconomicevaluation-2005","authorIDs":[],"author_short":["Wilby, J.","Kainth, A","Hawkins, N","Epstein, D","McIntosh, H","McDaid, C","Mason, A","Golder, S","O'Meara, S","Sculpher, M","others"],"bibdata":{"bibtype":"article","type":"article","title":"Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation","journal":"Health Technology Assessment","author":[{"propositions":[],"lastnames":["Wilby"],"firstnames":["Jennifer"],"suffixes":[]},{"propositions":[],"lastnames":["Kainth"],"firstnames":["A"],"suffixes":[]},{"propositions":[],"lastnames":["Hawkins"],"firstnames":["N"],"suffixes":[]},{"propositions":[],"lastnames":["Epstein"],"firstnames":["D"],"suffixes":[]},{"propositions":[],"lastnames":["McIntosh"],"firstnames":["H"],"suffixes":[]},{"propositions":[],"lastnames":["McDaid"],"firstnames":["C"],"suffixes":[]},{"propositions":[],"lastnames":["Mason"],"firstnames":["A"],"suffixes":[]},{"propositions":[],"lastnames":["Golder"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["O'Meara"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Sculpher"],"firstnames":["M"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"year":"2005","keywords":"Adolescent, Adult, Anticonvulsants, Clinical Trials as Topic, Cost-Benefit Analysis, Epilepsy, Female, Humans, Male, Randomized Controlled Trials as Topic, Treatment Outcome, United Kingdom","bibtex":"@article{wilby_clinical_2005-1,\n\ttitle = {Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation},\n\tjournal = {Health Technology Assessment},\n\tauthor = {Wilby, Jennifer and Kainth, A and Hawkins, N and Epstein, D and McIntosh, H and McDaid, C and Mason, A and Golder, S and O'Meara, S and Sculpher, M and {others}},\n\tyear = {2005},\n\tkeywords = {Adolescent, Adult, Anticonvulsants, Clinical Trials as Topic, Cost-Benefit Analysis, Epilepsy, Female, Humans, Male, Randomized Controlled Trials as Topic, Treatment Outcome, United Kingdom},\n}\n\n","author_short":["Wilby, J.","Kainth, A","Hawkins, N","Epstein, D","McIntosh, H","McDaid, C","Mason, A","Golder, S","O'Meara, S","Sculpher, M","others"],"bibbaseid":"wilby-kainth-hawkins-epstein-mcintosh-mcdaid-mason-golder-etal-clinicaleffectivenesstolerabilityandcosteffectivenessofnewerdrugsforepilepsyinadultsasystematicreviewandeconomicevaluation-2005","role":"author","urls":{},"keyword":["Adolescent","Adult","Anticonvulsants","Clinical Trials as Topic","Cost-Benefit Analysis","Epilepsy","Female","Humans","Male","Randomized Controlled Trials as Topic","Treatment Outcome","United Kingdom"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","creationDate":"2019-09-27T09:47:00.260Z","downloads":0,"keywords":["adolescent","adult","anticonvulsants","clinical trials as topic","cost-benefit analysis","epilepsy","female","humans","male","randomized controlled trials as topic","treatment outcome","united kingdom"],"search_terms":["clinical","effectiveness","tolerability","cost","effectiveness","newer","drugs","epilepsy","adults","systematic","review","economic","evaluation","wilby","kainth","hawkins","epstein","mcintosh","mcdaid","mason","golder","o'meara","sculpher","others"],"title":"Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation","year":2005,"dataSources":["t2Yoxo7tWvphNtRzd","ZaHtWavQhcwZqKLNF","dKPQSqAsJNG2yGZjP","iRRNaRs6FkffgErta","zDtGTy8C9ncqTdQuC","gZzkdjqc3Tjd8fnQA","sRQpsiPcuKR3Gwv8J","zeMwFvgpdRkYAkfoD","v8uQmZsBpiqycmskv"]}